BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Grahl MVC, Alcará AM, Perin APA, Moro CF, Pinto ÉSM, Feltes BC, Ghilardi IM, Rodrigues FVF, Dorn M, da Costa JC, Norberto de Souza O, Ligabue-Braun R. Evaluation of drug repositioning by molecular docking of pharmaceutical resources available in the Brazilian healthcare system against SARS-CoV-2. Inform Med Unlocked 2021;23:100539. [PMID: 33623816 DOI: 10.1016/j.imu.2021.100539] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Negru PA, Miculas DC, Behl T, Bungau AF, Marin R, Bungau SG. Virtual screening of substances used in the treatment of SARS-CoV-2 infection and analysis of compounds with known action on structurally similar proteins from other viruses. Biomedicine & Pharmacotherapy 2022;153:113432. [DOI: 10.1016/j.biopha.2022.113432] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Uppal T, Tuffo K, Khaiboullina S, Reganti S, Pandori M, Verma SC. Screening of SARS-CoV-2 antivirals through a cell-based RNA-dependent RNA polymerase (RdRp) reporter assay. Cell Insight 2022;1:100046. [DOI: 10.1016/j.cellin.2022.100046] [Reference Citation Analysis]
3 Alvarado YJ, Olivarez Y, Lossada C, Vera-Villalobos J, Paz JL, Vera E, Loroño M, Vivas A, Torres FJ, Jeffreys LN, Hurtado-León ML, González-Paz L. Interaction of the new inhibitor paxlovid (PF-07321332) and ivermectin with the monomer of the main protease SARS-CoV-2: A volumetric study based on molecular dynamics, elastic networks, classical thermodynamics and SPT. Comput Biol Chem 2022;99:107692. [PMID: 35640480 DOI: 10.1016/j.compbiolchem.2022.107692] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Gao K, Wang R, Chen J, Cheng L, Frishcosy J, Huzumi Y, Qiu Y, Schluckbier T, Wei X, Wei GW. Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2. Chem Rev 2022;122:11287-368. [PMID: 35594413 DOI: 10.1021/acs.chemrev.1c00965] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
5 Prasetyo WE, Kusumaningsih T, Wibowo FR. Gaining deeper insights into 2,5-disubstituted furan derivatives as potent α-glucosidase inhibitors and discovery of putative targets associated with diabetes diseases using an integrative computational approach. Struct Chem. [DOI: 10.1007/s11224-022-01994-0] [Reference Citation Analysis]
6 Uppal T, Tuffo K, Khaiboullina S, Reganti S, Pandori M, Verma SC. Screening of SARS-CoV-2 Antivirals Through a Cell-Based RNA-Dependent RNA Polymerase (RdRp) Reporter Assay.. [DOI: 10.1101/2022.04.04.486994] [Reference Citation Analysis]
7 Hart LR, Lebedenko CG, Mitchell SM, Daso RE, Banerjee IA. In Silico Studies of Tumor Targeted Peptide-Conjugated Natural Products for Targeting Over-Expressed Receptors in Breast Cancer Cells Using Molecular Docking, Molecular Dynamics and MMGBSA Calculations. Applied Sciences 2022;12:515. [DOI: 10.3390/app12010515] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Arruda E, Pires-neto R, Medeiros M, Quirino-filho J, Clementino M, Gondim R, Magalhães L, Cavalcante K, Viana V, Mello LP, Martins R, Santos A, Magalhães P, Havt A, Lopes N, Arruda-neto E, Lima A, study group members. Clinical Trial of Efficacy and Toxicity of Disoproxil Tenofovir Fumarate and Emtricitabine for Mild to Moderate SARS-CoV-2 Infections.. [DOI: 10.1101/2021.09.28.21264242] [Reference Citation Analysis]
9 Vergoten G, Bailly C. Interaction of the renin inhibitor aliskiren with the SARS-CoV-2 main protease: a molecular docking study. J Biomol Struct Dyn 2022;40:12714-22. [PMID: 34514971 DOI: 10.1080/07391102.2021.1976673] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Hesari Z, Zolghadri S, Moradi S, Shahlaei M, Tazikeh-lemeski E. Computational Discovery of SARS-CoV-2 NSP 16 Drug Candidates Based on Pharmacophore Modeling and Molecular Dynamics Simulation. J Comput Biophys Chem 2021;20:377-90. [DOI: 10.1142/s2737416521500198] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Zanella I, Zizioli D, Castelli F, Quiros-Roldan E. Tenofovir, Another Inexpensive, Well-Known and Widely Available Old Drug Repurposed for SARS-COV-2 Infection. Pharmaceuticals (Basel) 2021;14:454. [PMID: 34064831 DOI: 10.3390/ph14050454] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]